Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth

The regenerative process in the pancreas is of particular interest because diabetes results from an inadequate number of insulin-producing beta cells and pancreatic cancer may arise from the uncontrolled growth of progenitor/stem cells. Continued and substantial growth of islet tissue occurs after b...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 105; no. 50; pp. 19915 - 19919
Main Authors Inada, Akari, Nienaber, Cameron, Katsuta, Hitoshi, Fujitani, Yoshio, Levine, Jared, Morita, Rina, Sharma, Arun, Bonner-Weir, Susan
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 16.12.2008
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The regenerative process in the pancreas is of particular interest because diabetes results from an inadequate number of insulin-producing beta cells and pancreatic cancer may arise from the uncontrolled growth of progenitor/stem cells. Continued and substantial growth of islet tissue occurs after birth in rodents and humans, with additional compensatory growth in response to increased demand. In rodents there is clear evidence of pancreatic regeneration after some types of injury, with proliferation of preexisting differentiated cell types accounting for some replacement. Additionally, neogenesis or the budding of new islet cells from pancreatic ducts has been reported, but the existence and identity of a progenitor cell have been debated. We hypothesized that the progenitor cells are duct epithelial cells that after replication undergo a regression to a less differentiated state and then can form new endocrine and exocrine pancreas. To directly test whether ductal cells serve as pancreatic progenitors after birth and give rise to new islets, we generated transgenic mice expressing human carbonic anhydrase II (CAII) promoter: Cre recombinase (Cre) or inducible CreERTM to cross with ROSA26 loxP-Stop-loxP LacZ reporter mice. We show that CAII-expressing cells within the pancreas act as progenitors that give rise to both new islets and acini normally after birth and after injury (ductal ligation). This identification of a differentiated pancreatic cell type as an in vivo progenitor of all differentiated pancreatic cell types has implications for a potential expandable source for new islets for replenishment therapy for diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
1Present address: SSP Stem Cell Unit, Graduate School of Medicine, Kyushu University, Fukuoka, Japan.
2Present address: Center for Therapeutic Innovations in Diabetes, Department of Medicine, Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Edited by Donald F. Steiner, University of Chicago, Chicago, IL, and approved October 20, 2008
Author contributions: A.I., Y.F., A.S., and S.B.-W. designed research; A.I., C.N., H.K., J.L., R.M., and S.B.-W. performed research; A.I. and S.B.-W. analyzed data; and A.I., A.S., and S.B.-W. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0805803105